摘要
1文献来源Lee JM,Sepesi B,Toloza EM,et al.EP02.04-005 PhaseⅡNAUTIKA1 study of targeted therapies in stageⅡ-ⅢNSCLC:preliminary data of neoadjuvant alectinib for ALK+NSCLC[J].J Thorac Oncol,2022,17(9S):S233-S234.2.证据水平2b。
作者
张嘉涛
钟文昭
ZHANG Jia-tao;ZHONG Wen-zhao(Guangdong Lung Cancer Institute,Guangdong Provincial People’s Hospital(Guangdong Academy of Medical Sciences),Southern Medical University,Guangzhou 510080,China)
出处
《循证医学》
2023年第1期26-29,共4页
The Journal of Evidence-Based Medicine
关键词
非小细胞肺癌
新辅助靶向治疗
间变性淋巴瘤激酶
non-small cell lung cancer
neoadjuvant targeted therapy
anaplastic lymphoma kinase
